# US 8,278,332 B2 · Photostabilization of retinoids with alkoxycrylene compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 8,278,332 B2
- Document ID: US8278332B2
- Status: Granted
- Kind: B2
- Application number: 13/282,667
- Filed: 2011-10-27
- Published: 2012-03-15
- Granted: 2012-10-02
- Earliest claimed: 2007-08-09
- Assignees: Hallstar Innovations Corp.
- Inventors: Craig A. Bonda; Anna Pavlovic; Jean Zhang
- Web page: https://patentgrep.com/patent/US8278332B2

## CPC

- A61K 8/361: {Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof}
- A61K 8/368: with carboxyl groups directly bound to carbon atoms of aromatic rings
- A61K 8/37: Esters of carboxylic acids
- A61K 8/40: containing nitrogen (quinones containing nitrogen A61K8/355)
- A61K 8/49: containing heterocyclic compounds
- A61K 8/671: {Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal}
- A61P 17/00: Drugs for dermatological disorders
- A61P 17/02: for treating wounds, ulcers, burns, scars, keloids, or the like
- A61P 17/10: Anti-acne agents
- A61P 19/00: Drugs for skeletal disorders
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 35/00: Antineoplastic agents
- A61Q 17/04: Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
- A61Q 19/00: Preparations for care of the skin
- A61Q 19/08: Anti-ageing preparations
- A61K 2800/52: Stabilizers
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The photostabilizing electronic excited state energy—particularly singlet state energy from retinoid compounds—has been found to be readily transferred to (accepted by) α-cyanodiphenylacrylate compounds having an alkoxy radical in the four (para) position (hereinafter “alkoxycrylenes”) on one of the phenyl rings having the formula (I): wherein one of R1 and R2 is a straight or branched chain C1-C30 alkoxy radical, preferably C1-C8, more preferably methoxy, and the non-alkoxy radical R1 or R2 is hydrogen; and R3 is a straight or branched chain C1-C30 alkyl radical, preferably C2-C20. The alkoxycrylene compounds of formula (I) significantly increase the photostability of retinoid compounds in a composition by at least 3-fold.

## Claims

### Claim 1

A method for the anti-acne, anti-aging, wrinkle reducing, sunscreen, cosmetic or dermatological treatment of skin or hair comprising contacting the skin with a photostabilized composition comprising about 0.001% to about 5% by weight of a retinoid compound, and a compound of formula (I) in an amount of at least 0.1%, to about 20% by weight, based on the total weight of the composition, in a sunscreen, cosmetic or dermatological composition, wherein the compound formula (I) is
wherein one of R1 and R2 is a straight or branched chain C1-C30 alkoxy radical, and the non-alkoxy R1 and R2 is hydrogen; and R3 is a straight or branched chain C1-C30 alkyl radical.

### Claim 2 (depends on 1)

The method of claim 1, wherein R1 is methoxy and R2 is hydrogen.

### Claim 3 (depends on 1)

The method of claim 1, wherein R1 is hydrogen and R2 is methoxy.

### Claim 4 (depends on 1)

The method of claim 1, wherein R3 is a C12-C24 straight chain or branched alkyl.

### Claim 5 (depends on 4)

The method of claim 4, wherein R3 is a 2-butyloctyl radical.

### Claim 6 (depends on 4)

The method of claim 4, wherein R3 is an 2-ethylhexyl radical.

### Claim 7 (depends on 4)

The method of claim 4, wherein the compound of formula (I) is present in an amount in the weight range of about 0.1% to about 15%, based on the total weight of the composition.

### Claim 8 (depends on 7)

The method of claim 7, wherein the compound of formula (I) is present in an amount in this weight range of about 0.1% to about 10%, based on the total weight of the composition.

### Claim 9 (depends on 7)

The method of claim 7, wherein the compound of formula (I) is present in an amount in this weight range of about 0.1% to about 5%, based on the total weight of the composition.

### Claim 10 (depends on 1)

The method of claim 1, wherein the retinoid compound is present in an amount in the weight range of about 0.001% to about 1%, based on the total weight of the composition.

### Claim 11 (depends on 10)

The method of claim 10, wherein the retinoid compound is present in this weight range of about 0.005% to about 1%, based on the total weight of the composition.

### Claim 12 (depends on 10)

The method of claim 10, wherein the retinoid compound is present in this weight range of about 0.01% to about 0.5%, based on the total weight of the composition.

### Claim 13 (depends on 1)

The method of claim 1, wherein a molar ratio of the retinoid compound to the compound of formula (I) is about 0.001 to about 1.

### Claim 14 (depends on 13)

The method of claim 13, wherein this molar ratio of the retinoid compound to the compound of formula (I) is about 0.005 to about 0.1.

### Claim 15 (depends on 13)

The method of claim 13, wherein the molar ratio of the retinoid compound to the compound of formula (I) is about 0.01 to about 0.06.

### Claim 16 (depends on 1)

The method of claim 1, wherein the retinoid compound is selected from the group consisting of retinol, retinal, tretinoin, isotretinoin, alitretinoin, etretinate, acitretin, bexarotene, tazarotene, and adapalene.

### Claim 17 (depends on 16)

The method of claim 16, wherein the retinoid compound is retinol.

### Claim 18 (depends on 16)

The method of claim 16, wherein the retinoid compound is isotretinoin.

### Claim 19 (depends on 16)

The method of claim 16, wherein the retinoid compound is tretinoin.

### Claim 20 (depends on 16)

The method of claim 16, wherein the retinoid compound is retinal.

### Claim 21 (depends on 16)

The method of claim 16, wherein the retinoid compound is alitretinoin.

### Claim 22 (depends on 16)

The method of claim 16, wherein the retinoid compound is etretinate.

### Claim 23 (depends on 16)

The method of claim 16, wherein the retinoid compound is acitretin.

### Claim 24 (depends on 16)

The method of claim 16, wherein the retinoid compound is bexarotene.

### Claim 25 (depends on 16)

The method of claim 16, wherein the retinoid compound is tazarotene.

### Claim 26 (depends on 16)

The method of claim 16, wherein the retinoid compound is adapalene.
